6Marj olein L,Michael K,Andrew JS,et al.Neur ohor monal acti-vati on and thechr onic heart failure syndr ome in adultswith con-genital heart disease[J].Circ J,2002,106(1):922.
7Gower WR Jr,Chiou S,Skolnick KA,et al. Molecular forms of cir culating atria[7]natriuretic peptides in human plasma and their metabolites[J]. Peptides, 1994,15 : 86 le7.
8Lam CS,Burnett JC Jr,Costello-Boerrigter L,et al.Alternate cir-culating pro-B-type natriuretic peptide and B-type natriureticpeptide forms in the general population[J].J Am Coll Cardiol,2007,49:1193e202.
10Nakajima K,Onishi K,Dohi K,et al.Effects of human atrial natriureticpeptide on cardiac function and hemodynamics in patients with highplasma BNP levels[J].Int J Cardiol,2005,104:332e7.
3Publication Committee for the VMAC Investigators ( Vasodi- latation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure : a randomized controlled trial [ J ]. JAMA,2002,287 (12) :1531-1540.
4Carmine Savoia,Massimo Volpe.Angiotensin receptor modulation and cardiovascular remodeling. Journal of Renin-Angiotensin-Aldosterone System . 2011
5Lu Tong,Zhang Dai-Min,Wang Xiao-Li,He Tongrong,Wang Ru-Xing,Chai Qiang,Katusic Zvonimir S,Lee Hon-Chi.Regulation of coronary arterial BK channels by caveolae-mediated angiotensin II signaling in diabetes mellitus. Circulation Research . 2010
